India slashes cost of cancer drugs after court rules mark-ups are ‘extortion’

The Indian government has capped the prices of 137 cancer drugs, making them cheaper for millions of patients. This decision comes after a court ruling that the high mark-ups on these medicines are equivalent to extortion. The move aims to prevent poorer patients from having to choose between forgoing treatment, selling their assets, or taking on debt to afford the high cost of these life-saving medicines. This change could have a significant impact on the healthcare sector in India.

Why it matters

The Indian government's move to cap drug prices will make cancer treatments more affordable for millions of people. This could lead to increased demand for generic drugs and boost the Indian pharmaceutical industry.

Market impact

Markets & countries in focus

Transmission channels

Likely winners & losers

Explore the intelligence

MeridStreet does not reproduce source articles. The summary and analysis above are generated by MeridStreet from public headlines and its own market model; the original reporting belongs to The Guardian. For information only — not financial advice.